Literature. Case Rep Med. 2018;2018:1479850. \[[PMC free article: PMC5949181](/pmc/articles/PMC5949181/)\] \[[PubMed: 29853905](https://pubmed.ncbi.nlm.nih.gov/29853905)\] 3. Fukumoto LE, Fukumoto KD. Fat Embolism Syndrome. Nurs Clin North Am. 2018 Sep;53(3):335-347. \[[PubMed: 30100000](https://pubmed.ncbi.nlm.nih.gov/30100000)\] 4. Berlot G, Bussani R, Shafiei V, Zarrillo N. Fulminant Cerebral Fat Embolism: Case Description and Review of the Literature. Case Rep Crit Care. 2018;2018:7813175. \[[PMC free article: PMC6076907](/pmc/articles/PMC6076907/)\] \[[PubMed: 30105101](https://pubmed.ncbi.nlm.nih.gov/30105101)\] 5. Pane TA. Experience With High-Volume Buttock Fat Transfer: A Report of 137 Cases. Aesthet Surg J. 2019 Apr 08;39(5):526-532. \[[PubMed: 30099491](https://pubmed.ncbi.nlm.nih.gov/30099491)\] 6. Blokhuis TJ, Pape HC, Fr√∂lke JP. Timing of definitive fixation of major long bone fractures: Can fat embolism syndrome be prevented? Injury. 2017 Jun;48 Suppl 1:S3-S6. \[[PubMed: 28449860](https://pubmed.ncbi.nlm.nih.gov/28449860)\] 7. Pape HC, Giannoudis P, Krettek C. The timing of fracture treatment in polytrauma patients: relevance of damage control orthopedic surgery. Am J Surg. 2002 Jun;183(6):622-9. \[[PubMed: 12095590](https://pubmed.ncbi.nlm.nih.gov/12095590)\] 8. Dorr LD, Merkel C, Mellman MF, Klein I. Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop Relat Res. 1989 Nov;(248):112-8; discussion 118-9. \[[PubMed: 2805467](https://pubmed.ncbi.nlm.nih.gov/2805467)\] 9. Jorgensen A, Bashir A, Satpathy J. Cerebral fat embolism syndrome (FES): similar cases with different outcomes. BMJ Case Rep. 2018 Oct 08;2018 \[[PMC free article: PMC6194366](/pmc/articles/PMC6194366/)\] \[[PubMed: 30301725](https://pubmed.ncbi.nlm.nih.gov/30301725)\] 10. Misra I, Glasgow J, Moosavy F. Fat Emboli Syndrome. Del Med J. 2017 May;89(5):148-150. \[[PubMed: 29894029](https://pubmed.ncbi.nlm.nih.gov/29894029)\] **Disclosure:** Adebayo Adeyinka declares no relevant financial relationships with ineligible companies. **Disclosure:** Louisdon Pierre declares no relevant financial relationships with ineligible companies.